Patient Advocates, Providers, Laboratories and Diagnostic Manufacturers Urge Congressional Leaders to Modernize Regulation of Clinical Diagnostics
Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics and clinical laboratory tests to market. Read more.